Latest News

Lantheus and GE Healthcare to develop new PET imaging agent for CAD

Lantheus Holdings and GE Healthcare have signed a definitive licence agreement for the development and commercialisation of 'flurpiridaz F 18' for enhanced diagnosis of coronary artery disease...

Lantheus and GE Healthcare to develop new PET imaging agent for CAD

bioLytical introduces HIV self-test in Belgium

Canada-based bioLytical Laboratories has introduced INSTI HIV Self Test in pharmacies across...

bioLytical introduces HIV self-test in Belgium

ResMed develops new compact device for sleep apnoea

ResMed develops new compact device for sleep apnoea

Leica unveils new AR imaging technologies for surgical microscopes

Germany-based Leica Microsystems is set to unveil a new generation of augmented reality (AR) imaging technologies for surgical microscopes at the American Association of Neurological...

Leica unveils new AR imaging technologies for surgical microscopes

Synaptive's BrightMatter Plan secures CE mark and Australian regulatory approval

Synaptive's BrightMatter Plan secures CE mark and Australian regulatory approval

Meridian develops new sensitive diagnostic test for malaria

US-based life science company Meridian Bioscience has developed a new molecular-based, field laboratory-deployed test 'illumigene Malaria' to diagnose...

Meridian develops new sensitive diagnostic test for malaria

J&J's DePuy Synthes takes over TRS' 3D printing technology for bone defects

Johnson and Johnson (J&J) company DePuy Synthes Products has purchased 3D printing technology from Tissue Regeneration Systems (TRS) to treat bone...

J&J's DePuy Synthes takes over TRS' 3D printing technology for bone defects

STAT-Dx unveils new molecular diagnostics platform

Spanish diagnostic solutions provider STAT-Dx is set to unveil its new in-vitro diagnostics system DiagCORE at the 27th European Congress of Clinical Microbiology and Infectious Diseases...

STAT-Dx unveils new molecular diagnostics platform

Becton Dickinson agrees to buy Bard for $24bn

Becton Dickinson agrees to buy Bard for $24bn

Edwards gets FDA clearance for hemodynamic monitoring platform

US-based Edwards Lifesciences has obtained clearance from the US Food and Drug Administration (FDA) for its hemodynamic monitoring platform,...

Edwards gets FDA clearance for hemodynamic monitoring platform

Deals this week: HTG Molecular Diagnostics, Glytec, Cellnovo

Medical device company HTG Molecular Diagnostics has signed a research agreement with Centre Leon Berard, a non-profit organisation involved in molecular profiling studies, to advance...

Deals this week: HTG Molecular Diagnostics, Glytec, Cellnovo

Grail studies STRIVE blood tests to detect cancer early

Grail studies STRIVE blood tests to detect cancer early

M&As this week: Berkeley Advanced Biomaterials, NantOmic

GNI Group has entered an agreement to purchase 70% share in biologics company Berkeley Advanced Biomaterials (BAB), based in California, US, for a purchase consideration of $59.7m....

M&As this week: Berkeley Advanced Biomaterials, NantOmic

NuVasive introduces new trauma system for spinal surgery

US-based firm NuVasive has introduced portfolio of trauma system 'RELINE Trauma' for spine trauma...

NuVasive introduces new trauma system for spinal surgery

Roche collaborates with Sentara Consolidated Laboratories for diagnostic solutions

Pharmaceutical and diagnostic firm Roche has entered a strategic alliance with Sentara Consolidated Laboratories, recognising the organisation as a Roche Molecular Centre of Excellence...

Roche collaborates with Sentara Consolidated Laboratories for diagnostic solutions

FDA releases electroCore's vagus nerve stimulator for episodic headaches

FDA releases electroCore's vagus nerve stimulator for episodic headaches

France's Vexim launches new Masterflow Plus product in Germany

French medical device company Vexim has launched its new product Masterflow Plus in Germany for low-energy osteoporotic...

France's Vexim launches new Masterflow Plus product in Germany

Cardinal Health to gain Medtronic's medical products business for $6.1bn

Cardinal Health has signed a definitive $6.1bn agreement to acquire Medtronic's Minimally Invasive Therapies Group’s (MITG) patient care, deep vein thrombosis, and nutritional...

Cardinal Health to gain Medtronic's medical products business for $6.1bn

Boston Scientific begins trial to assess EMBLEM MRI S-ICD system

Boston Scientific begins trial to assess EMBLEM MRI S-ICD system

HTG and Daiichi Sankyo partner to develop diagnostic tests

US-based diagnostic firm HTG Molecular Diagnostics and Japanese pharmaceutical company Daiichi Sankyo have entered a master service agreement to develop diagnostic tests at the former's...

HTG and Daiichi Sankyo partner to develop diagnostic tests

FDA grants clearance to Philips' new digital pathology solution

FDA grants clearance to Philips' new digital pathology solution
cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1460672566_rd1460672566_371857150_ap1460672566_1857678299_1416951602